Braskem S.A.: Deep Value or Deep Distress? A High-Stakes Turnaround Hinges on Survival Amid Cyclical and Structural Turmoil
Braskem S.A. stands as the largest producer of thermoplastic resins in the Americas and a pivotal player in the global petrochemical industry. With a commanding market position in Brazil and substantial, strategically important operations in the United States, Mexico, and Europe, the company's core business revolves around the production of polyethylene (PE), polypropylene (PP), and polyvinyl chloride (PVC). These foundational materials are integral to a vast array of end markets, including packaging, automotive components, construction, and consumer goods.
The central investment thesis for Braskem is one of profound conflict. The company possesses a portfolio of world-class, well-integrated assets and a defensible market leadership that constitutes a formidable competitive advantage. However, this operational strength is currently besieged by a confluence of severe, potentially existential threats. These include a deep and prolonged cyclical downturn in the global petrochemical market that has decimated profitability , a crushing debt burden that has pushed the company into a state of acute financial distress , a massive and ongoing environmental liability stemming from a geological event in Alagoas, Brazil , and a debilitating ownership overhang as its controlling shareholder, Novonor, is compelled to divest its stake under judicial reorganization.
Recent developments have brought this crisis to a head. A cascade of credit rating downgrades from all major agencies has plunged the company's debt deep into non-investment grade, or "junk," territory, citing extreme leverage and negative cash flow. Critically, Braskem has formally announced the retention of financial and legal advisors to evaluate alternatives for optimizing its capital structure. This is an unambiguous signal that a significant balance sheet event, such as a distressed debt exchange or a broader restructuring, is now a distinct possibility.
Consequently, an investment in Braskem S.A. is a high-risk, high-potential-reward proposition centered on a deeply distressed asset. The ultimate outcome for equity holders hinges on the company's ability to navigate the immediate liquidity crisis and survive until an eventual, though uncertain, recovery in the petrochemical cycle materializes. This report will dissect the fundamental drivers, financial realities, and strategic challenges to model a range of potential outcomes, from a highly dilutive restructuring that results in significant capital loss to a scenario where survival and cyclical tailwinds unlock substantial value for current shareholders.
Braskem's operational foundation is its position as the only integrated first and second-generation petrochemical producer in Brazil. This integration, which spans from basic chemical feedstocks to finished thermoplastic resins, provides significant competitive advantages in production scale and operational efficiency. The company's business is structured around several key product lines and geographic regions.
The primary revenue drivers are its thermoplastic resins, which include:
Polyethylene (PE): A versatile plastic used extensively in packaging (films, bottles), consumer goods, and industrial applications. Braskem is the largest PE producer in Mexico through its Braskem Idesa joint venture.
Polypropylene (PP): A durable resin used in automotive components, rigid packaging, textiles, and household goods. Braskem is the largest PP producer in the United States, a position solidified through strategic acquisitions.
Polyvinyl Chloride (PVC): Primarily used in the construction industry for pipes, window frames, and flooring.
In addition to resins, Braskem produces a wide range of basic chemicals such as ethylene, propylene, butadiene, and benzene. These serve as essential feedstocks for its own polymer units and are also sold to third-party customers, further cementing its integrated position in the value chain.
A key element of Braskem's strategy has been geographic diversification. International operations in the United States, Mexico, and Europe now account for a substantial portion of the company's consolidated revenue and EBITDA, reducing its historical dependence on the often-volatile Brazilian economy. This global footprint provides access to different feedstock sources and end markets, offering a degree of resilience against regional downturns.
Braskem's enduring market strength is built on a clear and defensible competitive "moat."
Scale and Market Dominance: The company's most significant advantage is its dominant market share in Brazil, where it commands approximately 70% of the market for its key resins. This scale, combined with the country's underdeveloped logistics and distribution infrastructure for bulk chemicals, creates a formidable barrier to entry for imports, granting Braskem significant pricing power in its domestic market.
Feedstock Diversification: The petrochemical industry is heavily influenced by the cost of raw materials. Braskem has strategically diversified its feedstock base. While its Brazilian operations primarily use naphtha, a crude oil derivative, its international expansion has provided access to natural gas-based feedstocks like ethane. The Braskem Idesa project in Mexico and its U.S. assets are based on cost-advantaged ethane, providing crucial flexibility and a hedge against volatility in either oil or natural gas prices.
Integrated Operations: By controlling three of Brazil's largest petrochemical complexes, Braskem benefits from significant operational efficiencies and cost control. This integration allows the company to manage the value chain from basic inputs to higher-value polymers, capturing margin at each step.
Braskem's strategic priorities are currently split between immediate survival and long-term, value-accretive growth.
In the near term, the company is in "survival mode." In response to the severe industry downturn and its own financial distress, management has launched a series of aggressive cash preservation initiatives. These include rationalizing its asset base, prioritizing only the most critical investments, and implementing a rigorous cost reduction program. The stated goal of these measures is to generate an additional USD $500 million to $700 million in annual EBITDA, a crucial buffer against ongoing cash burn.
Contrasting with these defensive measures is the company's ambitious long-term strategy centered on sustainability and biopolymers. Braskem is a global pioneer in this field through its "I'm green™" brand of bio-based polyethylene, which is produced from sugarcane-derived ethanol rather than fossil fuels. This product line positions Braskem at the forefront of the growing global demand for renewable and sustainable materials. A recent expansion of its biopolymer facility is reportedly operating above its nameplate capacity, indicating strong market demand. This is complemented by the "Wenew" circularity ecosystem, an initiative focused on developing the plastic recycling supply chain and promoting a circular economy, further aligning the company with long-term ESG trends.
This creates a fundamental tension within the company's strategy. Its most compelling long-term differentiator and growth engine—the capital-intensive push into green chemistry and biopolymers—is directly threatened by its immediate and severe balance sheet crisis. The market is currently pricing Braskem based on the grim reality of its debt-laden, cyclical "brown" business, assigning little to no value to its pioneering "green" future. Should the company successfully navigate its financial restructuring and survive the current downturn, a significant re-evaluation could occur as the market recognizes the latent value in its sustainable technology portfolio. The core of the investment debate is whether this valuable long-term strategy can endure the short-term financial storm.
Braskem's recent financial performance starkly illustrates the severity of the industry downturn and the company's precarious position. The fiscal year 2024 was characterized by deep losses, with the company reporting a net loss of -$1.951 billion and a negative operating income of -74 million.
This collapse in earnings has translated into a severe and unsustainable rate of cash consumption. For the twelve months ending in June 2025, Braskem experienced a negative free cash flow of BRL 8.8 billion. The performance has been so poor that it has consistently undershot even bearish expectations. In its August 2025 rating action, S&P Global noted that Braskem's second-quarter results were "much weaker than expected," compelling the agency to significantly revise its forecasts downward for the remainder of the year and beyond.
The company's balance sheet is under extreme duress, defined by critically high leverage. Different rating agencies use slightly different methodologies, but all paint a similar picture of financial distress. As of June 2025, Moody's calculated Braskem's adjusted leverage (debt-to-EBITDA) at a staggering 15.3x. S&P Global projects the ratio will remain above a highly stressed 7.0x for both 2025 and 2026 , while Fitch Ratings anticipates leverage will be around 6.0x in 2025. These levels are dramatically above the company's own long-term target of 2.5x and are indicative of a capital structure that is unsustainable given the current earnings environment.
While Braskem reported a cash position of BRL 10.3 billion and access to a US$1 billion revolving credit facility as of June 2025, this liquidity buffer is being rapidly eroded by the ongoing cash burn. Recognizing this dynamic, S&P Global explicitly stated in its analysis that it "no longer view[s] Braskem's liquidity as a strength". The company's saving grace is a manageable near-term debt maturity profile, with relatively low repayments due through the end of 2026, which provides a narrow window to address its solvency issues before a maturity wall is hit.
With a market capitalization of approximately R1.1-1.2 billion), Braskem's equity is trading at deeply distressed levels. Traditional valuation multiples are largely meaningless in the current context. The Price-to-Earnings (P/E) ratio is not applicable due to significant negative earnings. The key valuation metric for a cyclical commodity business, Enterprise Value to EBITDA (EV/EBITDA), is also distorted and highly elevated due to the combination of a large debt load (which increases Enterprise Value) and trough-level EBITDA.
The current market valuation reflects a high probability of a severe credit event. Therefore, a rational valuation cannot be based on today's depressed earnings. Any analysis of Braskem's potential worth must instead focus on two forward-looking questions: first, what is the probability that the current equity survives an impending financial restructuring, and in what form? Second, what is the company's normalized, "mid-cycle" EBITDA generation capacity once the petrochemical cycle eventually turns? The investment thesis is predicated on the potentially vast gap between the current distressed valuation and a future valuation derived from applying a reasonable multiple to a normalized earnings figure. The exercise is less about valuing the company as it is today and more about valuing the option on its survival and recovery.
The table below summarizes the company's recent financial deterioration, providing a baseline for the forward-looking scenario analysis.
Note: 2024 figures derived from USD financials in and converted at an approximate 5.1 BRL/USD rate. 2025 figures are based on analyst consensus estimates from. Net Debt / EBITDA for 2025 is calculated using consensus figures.
Braskem faces an array of severe and interconnected risks that threaten its viability. These can be categorized into company-specific issues and broader macroeconomic headwinds.
Financial & Solvency Risk (CRITICAL): This is the most acute and immediate threat. The combination of extreme leverage, with adjusted debt-to-EBITDA ratios exceeding 15x by some measures, and a severe ongoing cash burn of nearly BRL 9 billion over the last year, has pushed the company to the brink of insolvency. The public hiring of restructuring advisors is a clear admission that the current capital structure is not viable and that a major balance sheet event is being actively contemplated. This poses a direct and substantial risk of massive dilution or a complete wipeout for current equity holders.
Alagoas Geological Liability: The environmental disaster related to the company's salt mining operations in Maceió, Alagoas, represents a significant and ongoing financial drain. While Braskem has provisioned billions of reais to cover relocation and compensation costs, there remains a risk of further liabilities and legal challenges. This open-ended liability has been a major impediment to strategic solutions, reportedly being a key reason that several potential acquirers, including Adnoc and LyondellBasell, abandoned their pursuit of the company.
Ownership Overhang & M&A Uncertainty: The company's ownership structure is a source of profound instability. The controlling shareholder, Novonor (formerly Odebrecht), is under judicial reorganization and is a forced seller of its stake, creating strategic paralysis. The second-largest shareholder is the Brazilian state-owned energy giant Petrobras, whose interests may not align with those of minority shareholders. The protracted and thus far unsuccessful sale process has left the company in a strategic limbo, unable to make critical long-term decisions or access equity markets to repair its balance sheet.
Feedstock Dependency and Counterparty Risk: Despite efforts to diversify, Braskem's operations remain exposed to volatile feedstock prices. Its Brazilian facilities are largely dependent on naphtha, whose price is linked to Brent crude oil, while its Mexican operations are critically dependent on a long-term contract for ethane supply from the state-owned Petróleos Mexicanos (Pemex). Any disruption in supply or adverse pricing movements from these key state-controlled suppliers represents a significant operational risk.
Prolonged Petrochemical Downturn: The primary driver of Braskem's operational losses is a global petrochemical downturn that Fitch Ratings has described as "unprecedented in depth and duration". This crisis is the result of a structural supply-demand imbalance. A massive wave of new production capacity, particularly in China and the U.S. Gulf Coast, came online just as global economic growth began to soften, leading to a supply glut. This has pushed industry-wide capacity utilization rates to ten-year lows and crushed profit margins (spreads) for key products like PE and PP.
The Structural Shift in China: The global petrochemical landscape has been fundamentally altered by a paradigm shift in China. For decades, the industry's growth was predicated on China's insatiable demand. However, the consensus long-term demand growth forecast for China has collapsed from a historical 6-8% annually to a more realistic 1-4%. Simultaneously, China has been aggressively building out its own domestic capacity, moving rapidly towards self-sufficiency and reducing its reliance on imports. This dual shock of slowing demand and increasing local supply has removed the world's primary growth engine for the industry.
Regulatory & ESG Pressure: The global chemical industry faces intensifying regulatory scrutiny and public pressure related to plastic waste management and carbon emissions. While Braskem's strategic investments in biopolymers and recycling position it well for this long-term trend, the near-term risk involves rising compliance costs and potential taxes or restrictions on single-use plastics, which could dampen demand.
Geopolitical and Foreign Exchange Risk: As a Brazilian multinational, Braskem is inherently exposed to political and economic instability in its key markets, particularly Brazil and Mexico. Furthermore, with a significant portion of its debt denominated in U.S. dollars while reporting in Brazilian Reais, the company is highly vulnerable to adverse movements in the BRL/USD exchange rate, which can inflate its debt and interest service costs in local currency terms.
These distinct risk factors do not exist in isolation; they are intertwined in a self-reinforcing negative feedback loop. The deep industry downturn decimates cash flow, which in turn makes the company's high debt load unserviceable. This acute financial distress, compounded by the open-ended Alagoas liability, scares away potential strategic buyers. The resulting ownership uncertainty and strategic paralysis prevent the company from taking the necessary decisive actions—such as a large-scale equity issuance—to fix its balance sheet. Breaking this vicious cycle will likely require a powerful external catalyst, such as a sharp and sustained recovery in petrochemical spreads that restores organic cash flow, or the successful resolution of the ownership situation with a new controlling shareholder willing and able to inject the capital needed to stabilize the enterprise.
This analysis projects Braskem's potential share price in five years under three distinct scenarios: a Low Case (Distressed Restructuring), a Base Case (Survival and Cyclical Recovery), and a High Case (Strong Recovery & Green Re-rating). The valuation is anchored on a terminal Enterprise Value to EBITDA (EV/EBITDA) multiple applied to projected Year 5 EBITDA. All monetary values are presented in Brazilian Reais (BRL). The analysis uses the current share price of R$8.85 as a reference for calculating returns but does not use it to derive price targets.
The model is driven by the following key inputs and assumptions, with provenance from the provided research:
Revenue: Projections begin with analyst consensus estimates for 2025 (R83.0 billion). Subsequent years are grown in line with global petrochemical market growth forecasts, which range from 5.6% to 7.5% annually.
EBITDA Margin: This is the most critical variable, acting as a proxy for petrochemical spreads. The starting point is derived from S&P and analyst consensus forecasts, implying a margin of ~7.5% in 2025, recovering to ~9% in 2026. A normalized mid-cycle margin for Braskem has historically been in the 15-20% range. The trajectory of this margin recovery is the primary differentiator between the scenarios.
Capital Expenditures (Capex): Assumed at maintenance levels of approximately US$400 million per year, as per S&P's base case, converted to BRL.
Net Debt: The starting point is the 2025 consensus forecast of R$53.7 billion. This figure is adjusted each year by the projected free cash flow (or cash burn).
Terminal EV/EBITDA Multiple: A mid-cycle multiple of 6.0x is used for the Base Case. This is a standard multiple for a large, cyclical commodity chemical company and is slightly more optimistic than the 5.5x emergence multiple used by S&P in its simulated default scenario.
Shares Outstanding: The current share count is 797.2 million. This figure is adjusted upwards in the Low Case to model dilution.
Subjective Probability: 50%
Narrative & Key Fundamentals: In this scenario, the petrochemical industry downturn proves to be "lower for longer." Weak global demand and persistent oversupply keep spreads and margins depressed through 2026 and into 2027. Braskem's EBITDA margin remains stuck in the 6-8% range. Despite management's cash preservation efforts , the company continues to burn cash. The high leverage becomes untenable, and to avoid a formal bankruptcy, the company is forced to execute a distressed debt-for-equity swap with its creditors. This transaction is massively dilutive to existing shareholders. For the purposes of this model, it is assumed that the share count quadruples to approximately 3.2 billion shares as debt holders are given a majority of the post-restructuring equity.
Projected Share Price (Year 5): R$5.52
5-Year Total Return: -37.6%
Subjective Probability: 40%
Narrative & Key Fundamentals: The petrochemical industry finds a bottom in 2025. A gradual recovery in global demand begins to absorb excess capacity through 2026, with spreads and margins normalizing by 2028. Braskem's EBITDA margin steadily recovers, moving from the current trough towards a more sustainable 12-14% range. The company's internal cost-cutting programs succeed in stabilizing cash flow , allowing it to narrowly avoid a dilutive restructuring, perhaps aided by non-core asset sales. The ownership situation is resolved with a new controlling shareholder who maintains the existing capital structure. Positive free cash flow generation resumes in 2027, enabling the company to begin a slow process of deleveraging.
Projected Share Price (Year 5): R$25.17
5-Year Total Return: +184.4%
Subjective Probability: 10%
Narrative & Key Fundamentals: A surprisingly robust global economic recovery from 2026 onwards, combined with significant competitor capacity shutdowns in high-cost regions like Europe, leads to a sharp, V-shaped recovery in petrochemical spreads. Braskem's EBITDA margins rebound quickly, reaching the high end of their historical range at 18-20%. A strong new strategic owner acquires control, injects capital to accelerate debt reduction, and achieves a faster-than-expected resolution of the Alagoas liability. As the balance sheet heals, the market begins to recognize the significant value of Braskem's "I'm green" biopolymer business , assigning a premium valuation multiple to the company to reflect its leadership in sustainable chemicals.
Projected Share Price (Year 5): R$48.24
5-Year Total Return: +445.1%
The following tables detail the financial projections for each scenario and summarize the valuation outcomes.
Table 1: 5-Year Scenario Financial Projections (BRL Millions, except per-share data)
Table 2: Share Price Trajectory & Probability-Weighted Outcome
In the Low Case, the calculated equity value is negative. The target share price of R$5.52 reflects a post-restructuring valuation where new equity is injected, and the share count is diluted, leaving some residual value for existing holders rather than a complete wipeout. The probability-weighted calculation uses the target prices shown. The discrepancy in returns is due to the non-linear nature of outcomes in distressed situations.
The probability-weighted analysis yields a 5-year price target of R$28.32. This outcome is heavily skewed by the significant upside in the Base and High cases, but it is critical to recognize that the single most likely scenario (Low Case, 50% probability) results in a substantial loss of capital.
DISTRESSED DEEP VALUE
This scorecard provides a qualitative assessment of Braskem across ten key factors, with each scored on a scale of 1 (poor) to 10 (excellent).
Management Alignment (2/10): Alignment with minority shareholders is exceptionally weak. The controlling shareholder, Novonor, is a distressed, forced seller operating under judicial reorganization, prioritizing its own creditors over long-term value creation for Braskem. The second-largest shareholder, state-controlled Petrobras, has its own complex strategic and political objectives that may conflict with minority interests. There is no evidence of meaningful insider share ownership or recent open-market purchases by executives to signal confidence. The company's legacy includes a major bribery scandal that resulted in a global settlement of nearly $1 billion, which further undermines confidence in its governance framework.
Revenue Quality (6/10): Revenue is generated from the sale of commodity chemicals, making it inherently cyclical and susceptible to global supply-demand dynamics and feedstock price volatility. This is a low-quality characteristic. However, the score is elevated by mitigating factors, including strong, long-term relationships with a diverse customer base, a degree of product customization that fosters loyalty, and significant geographic diversification, which reduces dependence on any single economy.
Market Position (9/10): Braskem's market position is its single greatest strength. It is the undisputed leader in thermoplastic resins in the Americas. In its home market of Brazil, it holds a commanding market share of approximately 70%, which is protected by significant logistical barriers to entry for imports. Furthermore, it has established leading positions in key international markets, being the largest polypropylene producer in the U.S. and the largest polyethylene producer in Mexico. This is a world-class, top-tier market position.
Growth Outlook (4/10): The near-term growth outlook is poor, constrained by the severe industry-wide capacity glut that is expected to suppress volumes and pricing for the next 1-2 years. Long-term growth is tied to global GDP expansion and the more promising, higher-value biopolymer and circular economy segments. However, the company's ability to fund and capitalize on these long-term opportunities is severely jeopardized by its immediate financial crisis.
Financial Health (1/10): The company's financial health is critical. With leverage ratios at crisis levels (exceeding 15x by some measures), sustained negative free cash flow, and credit ratings slashed to 'CCC' territory, there is a high and explicit risk of default or a major debt restructuring. The company's own decision to hire financial advisors to explore capital structure alternatives confirms the gravity of the situation.
Business Viability (5/10): There is a crucial distinction between the viability of the industrial assets and the viability of the current corporate entity. Braskem's petrochemical complexes are world-class, efficient, and fundamentally viable operations. However, the financial structure built on top of these assets is not. This score reflects the significant risk that the current corporate entity may not survive in its present form, even if the underlying plants continue to operate under new ownership post-restructuring.
Capital Allocation (3/10): The company's historical track record on capital allocation is poor, marked by involvement in the "Lava Jato" corruption scandal which involved illicit payments to secure contracts. In the current environment, capital allocation is not a matter of strategic choice but of necessity. All discretionary spending has been eliminated, with capex slashed to minimum maintenance levels to preserve cash. There is zero capacity for shareholder-friendly actions like dividends or share buybacks; indeed, no dividends were paid in 2024.
Analyst Sentiment (3/10): The prevailing sentiment among financial analysts and rating agencies is overwhelmingly negative. Recent weeks have seen a flurry of downgrades from credit agencies S&P, Moody's, and Fitch, all pointing to deteriorating credit metrics and heightened restructuring risk. Equity analysts have also turned more cautious, with firms like UBS downgrading the stock and slashing price targets. The consensus reflects deep concern over the company's financial stability.
Profitability (1/10): The company is currently deeply unprofitable. It is reporting significant negative net income and, more alarmingly, negative operating income, indicating that the core business is not covering its operational costs at current market prices. Margins are at or near record lows, crushed by the collapse in petrochemical spreads.
Track Record (4/10): Braskem has a mixed track record. The management teams of the past successfully executed a complex consolidation to create a national champion, followed by a successful international expansion strategy that built a leading position in the Americas. However, this legacy of value creation has been severely tarnished in recent years by the corruption scandal and the Alagoas geological disaster, and shareholder value has been decimated by the current cyclical downturn and balance sheet crisis.
Overall Blended Score: 3.8/10
STRONG ASSETS, BROKEN BALANCE-SHEET
Braskem S.A. is at a critical inflection point where its formidable operational strengths are being completely overshadowed by a balance sheet on the verge of collapse. The investment case is not a story of growth, but one of survival. The near-term outlook is perilous, dominated by the high probability of a debt restructuring that could be severely dilutive to current equity holders. The medium-to-long-term outlook is entirely dependent on the timing and magnitude of a recovery in the deeply cyclical global petrochemical market. An investment in Braskem today is a speculative, deep-value proposition with a binary range of potential outcomes.
Key catalysts that will determine the future path of the company's stock include:
Positive Catalysts: A faster-than-expected recovery in polyethylene and polypropylene spreads, driven by a rebound in global demand or competitor capacity rationalization. A successful and timely sale of the company to a strong strategic buyer willing to inject capital and stabilize the balance sheet. Favorable government actions in Brazil, such as the implementation of higher import tariffs or tax relief measures that would bolster domestic profitability. A final and capped resolution of the Alagoas environmental liability that removes the open-ended risk.
Negative Catalysts: A prolonged "lower-for-longer" industry downturn that extends the period of cash burn. A forced debt restructuring that results in the issuance of a massive number of new shares to creditors, wiping out most or all of the value for existing equity holders. The discovery of additional, unforeseen liabilities related to the Alagoas incident. A failed M&A process that leaves the company in its current state of strategic limbo with a distressed controlling shareholder.
The investment thesis for Braskem's equity is that it represents a high-risk, deep-value option on corporate survival and cyclical recovery. The current market price correctly reflects a high probability of a credit event. For an equity investment made today to be successful, an investor must believe that two conditions will be met: first, that any impending restructuring will be structured in a way that leaves some residual value for current shareholders (i.e., the dilution in the Low Case scenario is not 100%). Second, that the normalized, mid-cycle earnings power of Braskem's world-class assets is substantial enough to command a much higher valuation once the balance sheet is repaired and the industry cycle turns. The probability-weighted 5-year price target of R$28.32 suggests significant potential upside from the current price, but this must be weighed against the very real 50% probability assigned to a scenario that results in a significant loss of capital.
SURVIVE, THEN THRIVE
The stock of Braskem S.A. (BRKM3.SA) is in a severe and protracted downtrend. It has lost over 60% of its value over the past year and is currently trading at or near its 52-week low of R$7.80. The price is trading significantly below all major long-term and short-term moving averages, a classic sign of technical weakness, with key indicators like the Relative Strength Index (RSI) in or near oversold territory.
Recent price action has been overwhelmingly driven by negative fundamental news flow, with sharp declines following the announcements of credit rating downgrades and the hiring of restructuring advisors. The short-term outlook remains decidedly bearish. The stock is technically broken, and the fundamental news backdrop is negative. Until there is a clear and credible catalyst that fundamentally addresses the company's solvency concerns, any near-term rallies are likely to be short-lived and met with selling pressure.
DEEPLY OVERSOLD
View Braskem S.A. (BRKM3.SA) stock page
Loading the interactive version of this report…